12:20pm ET
Health and Healthcare
Vertex Scores Key Analyst Upgrade on Top of Making an Acquisition
On top of the company announcing an acquisition on Tuesday, Vertex has seen a substantial analyst upgrade from Goldman Sachs.
Jon C. Ogg
Companies
/Healthcare
Vertex Pharmaceuticals Inc
$508.34
▼ $8.00 (−1.55%) today
Markets closed · 9:01am ET
VRTX Coverage
Page 6 Jon C. Ogg 11:55am ET
Health and Healthcare
Vertex Pharmaceuticals and Other Biotech Stocks With Recent Golden Crosses
Here are three biotech stocks that recently saw their 50-day moving average cross above the 200-day average, a golden cross, plus two that went the other way.
11:40am ET
Health and Healthcare
Citigroup Sees Big Upside for 2 of the Largest Biotechs
Despite the wearing down of hepatitis C drugs and the political climate targeting drug prices, this analyst sees stabilization and predictability in the base businesses of two key biotech leaders.
9:05am ET
Investing
Tuesday’s Top Analyst Upgrades and Downgrades: Tesla, Uber, Amgen, Biogen, Gilead, Deckers, Vertex Pharma, KKR and More
24/7 Wall St. reviews dozens of analyst research reports each day of the week to find new ideas for investors and traders alike. Some of these analyst reports cover stocks to buy,…
12:15pm ET
Health and Healthcare
What CRISPR Has Planned for Transfusion-Dependent Beta Thalassemia
CRISPR Therapeutics shares jumped on Tuesday after the firm announced that the FDA has granted Fast Track Designation for its treatment for transfusion-dependent beta thalassemia.
Chris Lange 8:45am ET
Investing
Top Analyst Upgrades and Downgrades: Alcoa, Apple, Autodesk, BB&T, Bed Bath & Beyond, Camping World, Nvidia, Vertex, Voya and More
The top analyst upgrades, downgrades and initiations seen on Tuesday included Alcoa, Apple, Autodesk, BB&T, Bed Bath & Beyond, Camping World, Nvidia, Vertex Pharmaceuticals and Voya Financial.
8:45am ET
Investing
Top Analyst Upgrades and Downgrades: Boeing, Booking, Camping World, Domino’s, iRobot, MetLife, Neogen, Southern Copper, Vertex, Worldpay and More
The top analyst upgrades, downgrades and initiations seen on Tuesday included Boeing, Booking, Camping World, Domino's Pizza, iRobot, MetLife, Neogen, Southern Copper, Vertex Pharmaceuticals and Worldpay.
8:35am ET
Health and Healthcare
Major Biopharma Catalysts Coming in the First Quarter of 2019
Here, 24/7 Wall St. includes a calendar of a few of the biggest companies expecting clinical trial and FDA updates in the first quarter of 2019.
Chris Lange 9:15am ET
Investing
Top Analyst Upgrades and Downgrades: Aflac, Akamai, BioMarin, Caesars Entertainment, CBS, Crocs, GW Pharma, Medtronic, Netflix, Sirius XM and More
The top analyst upgrades, downgrades and initiations seen on Wednesday included Aflac, Akamai, BioMarin, Caesars Entertainment, CBS, Crocs, GW Pharma, Medtronic, Netflix and Sirius XM.
9:10am ET
Investing
Top Analyst Upgrades and Downgrades: Apple, Baker Hughes, Biogen, FedEx, Intel, Micron, Roku, Shake Shack and More
The top analyst upgrades, downgrades and initiations seen on Wednesday included Apple, Baker Hughes, Biogen, FedEx, Intel, Micron Technology, Roku and Shake Shack.
7:05am ET
Health and Healthcare
5 Merrill Lynch US 1 Health Care Stocks Could Be Big 2019 Winners
Here are five top health care stocks that provide investors with different avenues to invest in the sector. They all should be solid additions to growth portfolios for 2019.
12:05pm ET
Health and Healthcare
CRISPR Wins FDA Approval for Human Trials
CRISPR Therapeutics shares made a handy gain on Thursday after the company announced a key FDA decision concerning its collaboration with Vertex Pharmaceuticals.
Chris Lange 8:35am ET
Health and Healthcare
Merrill Lynch Loves Large Cap Biotech: 4 Top Stocks to Buy Now
Merrill Lynch recently highlighted sectors it considers a good opportunity now that are likely to outperform in the near term, and the sector that rated highest was biotechnology.
8:45am ET
Health and Healthcare
Stifel Has Red-Hot Biotech Stocks to Buy With Huge Upside Potential
A series of new Stifel research reports focus on three biotech companies that have upcoming clinical data that could prove to be huge.
11:15am ET
Health and Healthcare
Vertex Wins FDA Approval for Expanded Cystic Fibrosis Treatment
Vertex Pharmaceuticals shares saw a handy gain on Thursday after the FDA gave a nod to Vertex’s cystic fibrosis treatment.
Chris Lange